AEON Biopharma, Inc. 10-Q filing
Filed 2025-08-12 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001837607-25-000066
- Form type
- 10-Q
- CIK
- 0001837607
- Primary document
- https://www.sec.gov/Archives/edgar/data/1837607/000183760725000066/aeon-20250630x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AEON Biopharma, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-4.8M | - | - |
| Net Income | $2.5M | - | - |
| Eps Basic | 0.32 | - | - |
| Eps Diluted | 0.31 | - | - |
| Cash And Equivalents | $8.4M | - | - |
| Total Assets | $11.7M | - | - |
| Total Liabilities | $27.5M | - | - |
| Shareholders Equity | $-15.9M | - | - |
| Operating Cash Flow | $-10.0M | - | - |
| Capital Expenditures | $4,000 | - | - |